Phenylacetic acid derivatives as hPPAR agonists

Phenylacetic acid derivatives as hPPAR agonists Revisiting glitazars: Thiophene substituted oxazole containing α-ethoxy phenylpropanoic acid derivatives as highly potent PPARα/γ dual agonists devoid of adverse effects in rodents Amphipathic 3-Phenyl-7-propylbenzisoxazoles; human pPaR γ, δ and α agonists Synthesis and evaluation of a series of benzopyran derivatives as PPAR α/γ agonists Discovery of a Novel Series of Peroxisome Proliferator-Activated Receptor α/γ Dual Agonists for the Treatment of Type 2 Diabetes and Dyslipidemia Design and synthesis of oxime ethers of α-acyl-β-phenylpropanoic acids as PPAR dual agonists (S)-3-(4-(2-(5-Methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)-2-(piperazin-1-yl)propanoic acid compounds: Synthesis and biological evaluation of dual PPARα/γ agonists (−)3-[4-[2-(Phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic Acid [(−)DRF 2725]:  A Dual PPAR Agonist with Potent Antihyperglycemic and Lipid Modulating Activity Benzoxazinones as PPARγ agonists. part 1: SAR of three aromatic regions N-(2-Benzoylphenyl)-<scp>l</scp>-tyrosine PPARγ Agonists. 1. Discovery of a Novel Series of Potent Antihyperglycemic and Antihyperlipidemic Agents